Bioventus Cash Conversion Cycle 2011-2026 | BVS

Annual Cash Conversion Cycle Bioventus

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
224	215	208	187	117	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
224	117	190

Quarterly Cash Conversion Cycle Bioventus

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
232	225	254	222	215	259	234	184	202	-	202	175	190	-	163	153	210	-	190	266	104	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
266	104	204

Cash Conversion Cycle of other stocks in the Diagnostics research industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	50.2	-	-6.23 %	$ 30.6 M	Germany
ICON Public Limited Company ICLR	62	$ 98.33	0.9 %	$ 8.11 B	Irlanda
Akumin AKU	36.1	-	-17.87 %	$ 25.9 M	Canada
Aspira Women's Health AWH	-38.7	-	-6.19 %	$ 10.5 M	USA
Charles River Laboratories International CRL	65	$ 155.46	1.83 %	$ 7.71 B	USA
DexCom DXCM	134	$ 64.24	-1.56 %	$ 25.1 B	USA
Castle Biosciences CSTL	45.9	$ 25.56	0.95 %	$ 710 M	USA
CareDx, Inc CDNA	51.5	$ 17.01	3.4 %	$ 906 M	USA
Accelerate Diagnostics AXDX	364	-	-61.36 %	$ 2.46 M	USA
Exact Sciences Corporation EXAS	42.5	$ 103.57	0.29 %	$ 19.5 B	USA
Guardant Health GH	79.6	$ 85.49	1.75 %	$ 10.7 B	USA
Global Cord Blood Corporation CO	184	-	-	$ 399 M	China
Genetic Technologies Limited GENE	11 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	142	-	0.12 %	$ 80.1 M	China
Fulgent Genetics FLGT	42.4	$ 14.77	0.61 %	$ 447 M	USA
PRA Health Sciences, Inc. PRAH	1.21 K	-	-	$ 10.7 B	USA
Biodesix BDSX	41.7	$ 17.88	-6.63 %	$ 2.32 B	USA
Anixa Biosciences ANIX	275	$ 2.83	-1.05 %	$ 91.8 K	USA
Danaher Corporation DHR	77.5	$ 187.32	0.57 %	$ 134 B	USA
IQVIA Holdings IQV	73.9	$ 164.72	1.1 %	$ 28.3 B	USA
Biocept BIOC	78.1	-	-13.05 %	$ 7.29 M	USA
Heska Corporation HSKA	138	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	104	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	142	$ 118.94	2.92 %	$ 18.9 B	USA
Quest Diagnostics Incorporated DGX	39.5	$ 199.7	-0.46 %	$ 22.2 B	USA
QIAGEN N.V. QGEN	122	-	-	$ 10.6 B	Niderland
Agilent Technologies A	111	$ 111.51	-0.06 %	$ 33.9 B	USA
BioNano Genomics BNGO	225	$ 1.11	-0.89 %	$ 1.41 M	USA
DarioHealth Corp. DRIO	207	$ 9.0	-0.99 %	$ 255 M	Israel
Neogen Corporation NEOG	150	$ 9.09	-2.78 %	$ 1.97 B	USA
National Research Corporation NRC	29.4	$ 16.52	0.12 %	$ 370 M	USA
Chembio Diagnostics CEMI	111	-	0.22 %	$ 16.8 M	USA
Pacific Biosciences of California PACB	185	$ 1.33	4.72 %	$ 399 M	USA
Co-Diagnostics CODX	299	-	-	$ 79.8 M	USA
Medpace Holdings MEDP	50.4	$ 450.41	1.48 %	$ 13 B	USA
DermTech DMTK	66.7	-	-11.32 %	$ 2.94 M	USA
Mettler-Toledo International MTD	66.4	$ 1 173.74	0.49 %	$ 24.2 B	Schweiz
Personalis PSNL	-11.5	$ 6.72	1.97 %	$ 398 M	USA
NeoGenomics NEO	82.4	$ 7.88	-1.25 %	$ 1.01 B	USA
Enzo Biochem ENZ	154	-	-8.98 %	$ 14.8 K	USA
Natera NTRA	81.5	$ 187.85	-1.29 %	$ 18.5 B	USA
Sotera Health Company SHC	33.5	$ 13.42	0.71 %	$ 3.81 B	USA
Invitae Corporation NVTA	299	-	-	$ 21.2 M	USA
OPKO Health OPK	242	$ 1.19	2.59 %	$ 826 M	USA